Cargando…
非小细胞肺癌EGFR-TKI治疗临床获益后颅内转移机制研究进展
Currently epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is widely used for treatment of non-small cell lung cancer (NSCLC) patients with EGFR mutation. However, intracranial metastasis and progression could happen to some patients while their primary tumors in lung stabilize...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000228/ https://www.ncbi.nlm.nih.gov/pubmed/26302350 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.08.09 |